• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Home Healthcare Market is Expected to Reach $340.2B

by Fred Pennic 02/16/2023 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Aetna Taps Emcara Health to Deliver Home-Based Primary Care to 240k Medicaid Patients

What You Should Know:

– Home Healthcare market in terms of revenue was estimated to be worth $226 Billion in 2022 and is poised to reach $340.2 billion by 2027, growing at a CAGR of 8.5% from 2022 to 2027 according to a latest report published by MarketsandMarkets™.

– The report reveals growth in this market is mainly driven by rapid growth in the elderly population, and the rising incidence of chronic diseases.

Rising Demand for Home-Health Services & Solutions

The home healthcare industry is expected to experience rapid growth in the near future due to increased demand for home-based care services. The aging population, improvements in technology, and consumer preferences are driving the growth of home healthcare. This trend is likely to continue as more people seek out home healthcare services instead of going to a hospital or nursing home.

In addition, telemedicine and remote patient monitoring are becoming more popular as a way to provide healthcare services from a distance. This technology is expected to further drive growth in the home healthcare industry. As more people become comfortable with this technology, more providers will be willing to offer these services.

Advances in robotics are expected to revolutionize the home healthcare industry. Robots will be able to assist with a variety of tasks, from taking vital signs and administering medication to providing companionship and social interaction with patients. This will allow home healthcare providers to offer more comprehensive services and increase the number of patients they can care for.

Home Healthcare Market Drivers

The home healthcare industry is expected to experience rapid growth in the near future due to increased demand for home-based care services. Key market drivers include:

Growing elderly population: The global population of people aged 65 and over is expected to grow from 703 million in 2019 to 1.5 billion by 2050. This growing elderly population is driving the demand for home healthcare services.

Increase in chronic diseases: The prevalence of chronic diseases is increasing globally due to lifestyle changes, such as unhealthy diets, physical inactivity, and smoking. This is driving the need for home healthcare services as these patients require continuous monitoring and care.

Technological advancements: Technological advances, such as telehealth, remote patient monitoring, and artificial intelligence, are driving the growth of the home healthcare market. These technologies enable healthcare providers to provide quality healthcare services remotely.

Increasing government initiatives: Governments around the world are taking initiatives to promote the adoption of home healthcare services. These initiatives aim to reduce healthcare costs and improve patient outcomes.

Growing preference for home healthcare services: Patients are increasingly opting for home healthcare services due to their convenience and cost-effectiveness. In addition, home healthcare services reduce the risk of nosocomial infections, which are associated with hospital stays.

Recent Home Health M&A Activity

Humana and Walgreens Boots Alliance: In January 2022, Walgreens Boots Alliance (WBA) and Humana announced that they had reached a definitive agreement to combine their respective businesses in a merger of equals. The transaction is expected to close in the second half of 2022.

CVS Health and Aetna: In March 2022, CVS Health and Aetna announced that they had reached a definitive agreement to merge their respective businesses. The transaction is expected to close in the second half of 2022.

UnitedHealth Group and DaVita HealthCare Partners: In May 2022, UnitedHealth Group and DaVita HealthCare Partners announced that they had reached an agreement to merge their respective businesses. The transaction is expected to close in the second half of 2022.

Optum and MedExpress: In June 2022, Optum and MedExpress announced that they had reached a definitive agreement to merge their respective businesses. The transaction is expected to close in the second half of 2022.

Kindred Healthcare and Gentiva Health Services: In July 2022, Kindred Healthcare and Gentiva Health Services announced that they had reached a definitive agreement to merge their respective businesses. The transaction is expected to close in the second half of 2022.

Click here for more information about the report, visit

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Aetna, Artificial Intelligence, CVS Health, home health, home healthcare, Humana, M&A, medication, Optum, Partners, Patient Monitoring, remote patient monitoring, risk, telemedicine, Vital, Walgreens

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |